Pomegranate Cholesterol Meta-analysis: What the Evidence Says

Quick Answer

Pomegranate Cholesterol Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 systematic review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• One of the major risk factors for CVD is an elevated concentration of blood lipids such as cholesterol and triglycerides (TGs) which are present in over 50% of adults (Boren et al. [Ghaemi Fatemeh (2026); evidence level 1]
• The accumulation of fatty deposits in the arteries, known as atherosclerosis, is associated with an increased risk of blood clots and is commonly found in individuals with CVD (Rafieian-Kopaei et al. [Ghaemi Fatemeh (2026); evidence level 1]
• These metabolic comorbidities substantially elevate the risk for long-term cardiovascular and metabolic diseases. [Silveira Vitória (2025); evidence level 1]
• Alongside medical interventions, non-pharmacological strategies-particularly those centered on dietary modification and increased physical activity-have become integral components of PCOS care, aimed at addressing associated metabolic and cardiovascular risks. [Silveira Vitória (2025); evidence level 1]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For pomegranate cholesterol meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Ghaemi Fatemeh (2026). Pomegranate juice consumption and lipid profile: An updated systematic review and meta-analysis. DOI: 10.22038/ajp.2025.26398. PMCID: PMC13180246. PMID: 42153011. License: https://creativecommons.org/licenses/by-nc/4.0/ https://creativecommons.org/licenses/by-nc/4.0/ This work is licensed.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13180246/
• Silveira Vitória (2025). Effects of Pomegranate Juice on Androgen Levels, Inflammation and Lipid Profile in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. DOI: 10.3390/jcm14155458. PMCID: PMC12346944. PMID: 40807079. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12346944/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.